On December 26, 2025, Can-Fite BioPharma announced that Brazil’s patent office granted a patent protecting the use of its A3 adenosine receptor agonist technology for the treatment of sexual ...

An online program called eSense appeared to be effective for the treatment of sexual interest/arousal disorder (SIAD) in women, according to new research. The program led to significant improvement in ...

Dyspareunia affects women of all ages with cancer, so assess pain location, intensity, and dryness, as well as partner ...

Please provide your email address to receive an email when new articles are posted on . A cognitive behavioral therapy protocol improved symptoms of decreased sexual desire. Women also reported ...

Understanding erectile dysfunction causes, ED symptoms, and hidden health risks in men's health. Learn linked conditions, ...

Maybe you’ve been wondering if dissatisfaction with your sex life is sexual dysfunction or actual incompatibility with your partner. Sexual contact in your relationship may not be happening as ...

Low libido is a lack of sexual desire or interest. Orgasmic disorders cause difficulty achieving orgasm, even with enough arousal. Sexual arousal disorder includes problems with getting or staying ...

U.S. Patent No. 12,496,316, entitled “Treatment of Sexual Dysfunction and Improvement in Sexual Quality of Life,” provides Longeveron with patent rights in the United States through 2038. Further ...

Female sexual interest/arousal disorder (FSIAD) is a type of sexual dysfunction. A person with the condition may experience a lack of sexual desire, a lack of physical arousal, or both. As with other ...